<DOC>
	<DOCNO>NCT00452790</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability immunogenicity 13-valent pneumococcal conjugate vaccine ( 13vPnC ) compare Prevenar ( 7vPnC ) , give concomitantly routine paediatric vaccination India .</brief_summary>
	<brief_title>Study Evaluating 13-valent Pneumococcal Conjugate Vaccine Healthy Infants India</brief_title>
	<detailed_description />
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Inclusion Criteria 1 . Healthy infant age 6 week ( 4272 day ) time enrolment 2 . Available entire study period Exclusion Criteria 1 . Previous vaccination pneumococcal , diphtheria , tetanus , pertussis Hib vaccines 2 . A previous anaphylactic reaction vaccine vaccinerelated component 3 . Contraindication vaccination pneumococcal , Hib , diphtheria , tetanus , pertussis , polio , hepatitis B measles vaccine</criteria>
	<gender>All</gender>
	<minimum_age>42 Days</minimum_age>
	<maximum_age>72 Days</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Vaccines , Pneumococcal</keyword>
</DOC>